Swiss National Bank - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 251 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$6,186,551
-6.3%
161,994
+0.9%
0.01%
+25.0%
Q2 2023$6,601,118
-29.1%
160,494
-1.0%
0.00%
-33.3%
Q1 2023$9,311,558
-8.5%
162,194
-10.6%
0.01%
-14.3%
Q4 2022$10,176,369
+35.4%
181,494
+2.3%
0.01%
+40.0%
Q3 2022$7,514,000
-21.2%
177,394
+0.5%
0.01%
-16.7%
Q2 2022$9,536,000
-12.8%
176,494
+3.7%
0.01%0.0%
Q1 2022$10,937,000
+3.1%
170,194
+7.4%
0.01%0.0%
Q4 2021$10,611,000
-2.4%
158,394
-0.3%
0.01%
-14.3%
Q3 2021$10,874,000
+0.8%
158,794
+0.4%
0.01%0.0%
Q2 2021$10,788,000
-4.6%
158,094
-3.4%
0.01%
-12.5%
Q1 2021$11,303,000
+7.5%
163,594
+1.0%
0.01%
+14.3%
Q4 2020$10,517,000
+36.2%
161,994
-0.9%
0.01%
+16.7%
Q3 2020$7,720,000
+2.6%
163,494
+2.1%
0.01%0.0%
Q2 2020$7,528,000
+19.0%
160,194
+13.1%
0.01%
-14.3%
Q1 2020$6,325,000
-22.1%
141,594
+1.7%
0.01%
-12.5%
Q4 2019$8,118,000
-1.1%
139,294
+1.9%
0.01%
-11.1%
Q3 2019$8,211,000
+9.1%
136,694
+1.4%
0.01%
+12.5%
Q2 2019$7,528,000
+2.4%
134,794
+2.1%
0.01%0.0%
Q1 2019$7,355,000
+27.4%
131,994
+3.1%
0.01%
+14.3%
Q4 2018$5,773,000
-32.7%
127,994
-1.8%
0.01%
-30.0%
Q3 2018$8,582,000
+14.8%
130,294
+12.2%
0.01%
+11.1%
Q2 2018$7,478,000
+24.2%
116,094
+6.7%
0.01%
+28.6%
Q1 2018$6,021,000
+18.2%
108,794
+2.3%
0.01%
+40.0%
Q4 2017$5,092,000
+0.9%
106,394
+6.4%
0.01%
-16.7%
Q3 2017$5,048,000
-7.4%
99,9940.0%0.01%0.0%
Q2 2017$5,451,000
+31.6%
99,994
+1.7%
0.01%
+20.0%
Q1 2017$4,141,000
-1.8%
98,294
+100.0%
0.01%
-28.6%
Q4 2016$4,216,000
+6.1%
49,147
+2.1%
0.01%
+16.7%
Q3 2016$3,975,000
+2.6%
48,147
-0.8%
0.01%0.0%
Q2 2016$3,873,000
+22.7%
48,5470.0%0.01%0.0%
Q1 2016$3,156,000
+21.4%
48,547
+26.6%
0.01%0.0%
Q4 2015$2,599,000
+13.8%
38,3470.0%0.01%0.0%
Q3 2015$2,284,000
+19.4%
38,347
+35.0%
0.01%
+20.0%
Q2 2015$1,913,000
+11.2%
28,400
+1.8%
0.01%0.0%
Q1 2015$1,720,000
+15.4%
27,900
+1.5%
0.01%
-16.7%
Q4 2014$1,491,000
+12.1%
27,500
+2.6%
0.01%
+20.0%
Q3 2014$1,330,000
+5.5%
26,8000.0%0.01%0.0%
Q2 2014$1,261,000
+2.3%
26,8000.0%0.01%0.0%
Q1 2014$1,233,000
+24.8%
26,800
+29.5%
0.01%
+25.0%
Q4 2013$988,000
+37.2%
20,700
+15.6%
0.00%
+33.3%
Q3 2013$720,000
+0.8%
17,900
-8.2%
0.00%0.0%
Q2 2013$714,00019,5000.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q4 2018
NameSharesValueWeighting ↓
VeriStar Capital Management LP 268,000$10,234,9208.72%
Madison Avenue Partners, LP 964,667$36,840,6335.23%
Pavadi Capital LLC 99,999$3,818,9624.97%
KESTREL INVESTMENT MANAGEMENT CORP 122,450$4,6762.96%
Sapience Investments, LLC 245,700$9,383,2832.26%
Ellsworth Advisors, LLC 102,500$3,882,7001.38%
Point72 Europe (London) LLP 464,462$17,737,8041.09%
COOKE & BIELER LP 2,714,194$103,655,0691.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 75,586$2,886,6300.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,827$43,033,5230.95%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders